Research Article
Utilization and Dose Optimization of Angiotensin-Converting Enzyme Inhibitors among Heart Failure Patients in Southwest Ethiopia
Table 3
Type and dose of ACEIs used in HF patients (n=230).
| | Variables | Medications | | Enalapril | Captopril |
| | Number of patients on the medication (%) | 215 (93.5) | 15 (6.5) |
| | Number of patients on the optimal dose (%) | 81 (37.7) | 1 (6.7) |
| | Number of patients on 50 to <100% of the target dose (%) | 25 (11.6) | 5 (33.3) |
| | Number of patients on <50% of the target dose (%) | 109 (50.7) | 9 (60) |
| | Mean (SD) daily dose (mg/d) | 12 (8.3) | 55 (33.6) |
| | Median (IQR) dose received (mg) | 7.5 (5-20) | 37.5 (37.5-75) |
| | Minimum dose used (mg/d) | 2.5 | 18.75 |
| | Maximum dose used (mg/d) | 40 | 150 |
|
|
SD, standard deviation; IQR, interquartile.
|
